| abstract |
(57) [Summary] [PROBLEMS] To provide a novel therapeutic agent for tactile disorder. The present invention provides a therapeutic agent for tactile dysfunction, which contains a neurotrophin such as BDNF as an active ingredient. Perception of the skin resulting from various peripheral / central neuropathy caused by vitamin deficiency, poisoning, inflammatory disease, viral infection, diabetes, anticancer drug treatment, trauma, physical irritation in the occupational environment, psychosomatic disorder, etc. It can treat insufficiency, especially loss of touch or bluntness. |